October 2026
- dEEGtalCHF 100,000
dEEGtal, based at the Wyss Center on the Campus Biotech, uses AI to analyse electroencephalograms and refine epilepsy diagnosis.
- Juturna BioCHF 50,000
Juturna Bio, an EPFL spin-off based at the Campus Biotech, is developing epigenetic therapies to restore the function of ageing brain cells, with Alzheimer's as the first target.
- S-SENTIACHF 100,000
S-SENTIA, a University of Geneva spin-off, designs microchips that capture weak and fast signals, notably for 3D vision in robotics and medical imaging.
September 2026
- FlottandoAmount not disclosed
Flottando is developing an AI-based operating system that handles the administrative tasks linked to company vehicle fleets.
- GoodwallCHF 400,000
Goodwall is a platform that helps young people develop skills and find their career path through challenges set by employers.
- Infera NeuroCHF 50,000
An EPFL spin-off, Infera Neuro designs neural decoding chips for non-invasive brain-computer interfaces intended to restore speech.
- Roofless LabsCHF 50,000
Roofless Labs is developing K4MERA, a compact camera with four sensors that instantly produces 3D wigglegrams.
July 2026
- Immitra BioCHF 2.4 M
Immitra Bio is developing an in vivo gene-editing platform that does not depend on the mutation, with a lead candidate against an inherited anaemia.
June 2026
- TheraPPIAmount not disclosed
TheraPPI develops drugs that modulate protein interactions, with an oncology programme targeting ERK/MyD88 in the Ras-MAPK pathway.
May 2026
- Neurosoft BioelectronicsUSD 7.5 M
Neurosoft Bioelectronics develops flexible, stretchable brain-machine interfaces that have already been tested in 10 patients.
- AMP ITAmount not disclosed
AMP IT develops, finances and operates private electric vehicle charging stations through its AMP IT Hub platform.
April 2026
- Precise IntelligenceCHF 50,000
Precise Intelligence is developing AI agents that automate maritime chartering workflows.
- UNBOOUND Medical TechnologiesCHF 100,000
A spin-off of Rockefeller University developed with the HUG, UNBOOUND offers SMELL-RS, a standardised measure of olfactory function.
- YstorianCHF 50,000
Ystorian provides SMEs with a dashboard that continuously assesses their cybersecurity posture.
- PlanetaryCHF 16 M
Planetary is developing an integrated fermentation platform and licensing a technology that turns sugar by-products into protein.
- TerapetEUR 772,000
A CERN spin-off based in Geneva, Terapet develops PET-type technologies to verify in vivo the dose delivered in proton therapy.
March 2026
- PlairCHF 1 M
Plair sells RAPID-C+, a real-time viable particle counter for monitoring pharmaceutical cleanrooms.
- Agora CareCHF 2.2 M
Agora Care runs a secure platform that centralises patients' medical data, with an AI assistant.
February 2026
- NeutralityAmount not disclosed
Neutrality deploys cloud cybersecurity technologies, notably for humanitarian organisations.
- Clee MedicalAmount not disclosed
Clee Medical is developing a real-time, very high-resolution brain imaging platform for minimally invasive neurosurgery.
- AxyCHF 50,000
Axy is developing an AI platform that makes it easier to find work and network at scientific conferences.
- FlottandoCHF 50,000
Flottando publishes a cloud platform that automates the management of corporate vehicle fleets.
- Nose SwitzerlandCHF 20,000
Nose Switzerland combines an olfactory profiling kit with an app to tailor nutrition for cancer patients suffering from taste and smell disorders.
- Scenario XCHF 50,000
Scenario X is developing a hybrid AI-quantum platform for risk analysis and optimisation for financial institutions.
- Chronic.CHF 313,000
Chronic., the B2C brand of Geneva-based Bean2me, roasts and sells organic and fair-trade speciality coffee.
January 2026
- ORamaVRUSD 4.5 M
ORamaVR develops a medical extended reality software platform combining AI and simulation for healthcare training and planning.
- TECH5Amount not disclosed
TECH5 develops AI technologies for contactless biometric capture, multi-biometric matching and digital identity for governments and businesses.
- ClooverUSD 22 M
Cloover offers renewable energy installers an AI-based operating system that combines software, financing, procurement and energy management.
- FluoSpheraCHF 1.2 M
FluoSphera has developed an in vitro platform that combines up to seven human tissue models in a single well to predict drug efficacy and toxicity.
December 2025
- Geneva Connection TechnologiesCHF 50,000
Geneva Connection Technologies, a CERN spin-off, develops a method for micro-soldering radiation sensors onto silicon readout chips.
- POSICSCHF 50,000
POSICS, a project from the Faculty of Science at the University of Geneva, develops a wireless camera for radio-guided cancer surgery, with 3D imaging and augmented reality.
- VectopiaCHF 50,000
Vectopia, a University of Geneva spin-off, develops a new production method for lentiviral vectors used in gene therapy.
November 2025
- Xcert AICHF 1.1 M
Xcert AI develops an AI platform that automates certification and compliance in the aerospace industry.